new BindingDB logo
myBDB logout

13 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
9873586 50 PD 176252--the first high affinity non-peptide gastrin-releasing peptide (BB2) receptor antagonist.EBI Cambridge University Forvie Site
 66 Design and synthesis of a targeted set of aromatic amino acid derivatives for identification of new lead compoundsEBI TBA
 42 PD 165929 the first high affinity non-peptide neuromedin-B (NMB) receptor selective antagonistEBI TBA
24900253 28 Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of ObesityEBI TBA
20219372 114 Synthesis and SAR of derivatives based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesity.EBI Merck Research Laboratories
20167483 90 Discovery of substituted biphenyl imidazoles as potent, bioavailable bombesin receptor subtype-3 agonists.EBI Merck Research Laboratories
19553112 39 Discovery and optimization of a novel Neuromedin B receptor antagonist.EBI Amgen Inc.
18818070 28 Discovery of small molecule agonists for the bombesin receptor subtype 3 (BRS-3) based on an omeprazole lead.EBI GlaxoSmithKline
15634004 20 Potent bombesin-like peptides for GRP-receptor targeting of tumors with 99mTc: a preclinical study.EBI National Center for Scientific Research Demokritos
15149640 34 Identification and optimization of novel partial agonists of neuromedin B receptor using parallel synthesis.EBI Tularik Inc.
12723954 47 Design of selective peptidomimetic agonists for the human orphan receptor BRS-3.EBI Technische Universität München
26833890 18 Synthesis, Biological Evaluation, and Molecular Docking of 8-imino-2-oxo-2H,8H-pyrano[2,3-f]chromene Analogs: New Dual AChE Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease.BDB Yogi Vemana University
26914186 3 Arylazolyl(azinyl)thioacetanilides: Part 19: Discovery of Novel Substituted Imidazo[4,5-b]pyridin-2-ylthioacetanilides as Potent HIV NNRTIs Via a Structure-based Bioisosterism Approach.BDB Shandong University